Kirst H A, Willard K E, Debono M, Toth J E, Truedell B A, Leeds J P, Ott J L, Felty-Duckworth A M, Counter F T, Ose E E
Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285.
J Antibiot (Tokyo). 1989 Nov;42(11):1673-83. doi: 10.7164/antibiotics.42.1673.
Reductive amination of the C-20 aldehyde group of tylosin and related macrolides yielded a large series of derivatives with potentially useful antibiotic properties. Evaluation of these new compounds was conducted on the basis of: 1) Broad antimicrobial spectrum in vitro, with particular emphasis on inhibition of Pasteurella multocida and Pasteurella haemolytica; 2) in vivo efficacy, especially when given orally, against P. multocida in experimental infections in chicks; and 3) bioavailability after oral administration to laboratory animals. The most useful activity was found within a series of derivatives produced by reductive amination of desmycosin with secondary amines.
泰乐菌素及相关大环内酯类化合物C-20醛基的还原胺化反应产生了一大系列具有潜在有用抗菌特性的衍生物。这些新化合物的评估基于以下几点:1)体外具有广泛的抗菌谱,尤其着重于对多杀巴斯德菌和溶血巴斯德菌的抑制作用;2)体内疗效,特别是口服给药时,对雏鸡实验性感染中的多杀巴斯德菌的疗效;3)对实验动物口服给药后的生物利用度。在由去碳霉糖泰乐菌素与仲胺进行还原胺化反应生成的一系列衍生物中发现了最有用的活性。